As per a randomized clinic trial for patients with newly diagnosed multiple myeloma, low doses of dexamethasone (Decadron ®) along with lenalidomide (Revlimid ®) are helpful in improving survival rates to a considerable extent. This combination proved to out to a better option against a combination of lenalidomide and a high dosage of dexamethasone.

The treatment method will help all those patients suffering from Multiple myeloma, which is a cancer of plasma cells found in blood and bone marrow.

The trial was a part of the National Institutes of Health, which was sponsored by the National Cancer Institute (NCI), and was conducted by researchers led by the Eastern Cooperative Oncology Group (ECOG).

The new findings have been welcomed by all segments of the medical world and is seen as a real step forward in the right direction for treatment of Multiple Myeloma, as per study chair Vincent Rajkumar, M.D., Mayo Clinic, Rochester, Minn.

Comments

comments

Tags: dexamethasone, lenalidomide, multiple myeloma, steroids

Posted in Steroid Cycles, steroid nation, Steroids and Anabolic Steroids